Remix Therapeutics
Show contact
Links
Previous companies
Peter Smith
Co-Founder, & CEO
Matthew Schnaderbeck
Sr. Director, CMC
Rob Gagnon
CFO
Heather Wasserman
COO & Chief Business Officer
Zaven Kaprielian
Chief Scientific Officer
+ 3 more
April, 2022 - present
View in org chart
